Vaccination of mice with GRP94/gp96, the endoplasmic reticulum Hsp90, elicits a variety of immune responses sufficient for tumor rejection and the suppression of metastatic tumor progression. Macrophages are a prominent GRP94/gp96 target, with GRP94/gp96 reported to activate macrophage NF-B signaling and nitric oxide production, as well as the MAP kinase p38, JNK, and ERK signaling cascades. However, recent studies report that heat shock protein elicited macrophage activation is due, in large part, to contaminating endotoxin. To examine the generality of this finding, we have investigated the role of endotoxin in GRP94/gp96-elicited macrophage activation. We report that GRP94/ gp96 binds endotoxin in a high-affinity, saturable, and specific manner. Low endotoxin calreticulin and GRP94/ gp96 were purified, the latter using a novel method of depyrogenation; this resulted in GRP94/gp96 and calreticulin preparations with endotoxin levels substantially lower than those of previously reported preparations. Low endotoxin GRP94/gp96 retained its native conformation, ligand binding activity, and in vitro chaperone function, yet did not activate macrophage NF-B signaling, nitric oxide production or inducible nitric-oxide synthase production. Low endotoxin GRP94/gp96 and calreticulin did, however, elicit a marked increase in ERK phosphorylation at protein concentrations as low as 2 g/ml. These results are discussed with respect to current understanding of the contributions of endotoxin and heat shock/chaperone proteins to the stimulation of innate immune responses.
A number of molecular chaperones, including GRP94/gp96, calreticulin (CRT), 1 and Hsp70, are capable of eliciting antitumor immune responses against their tumor of origin (1) (2) (3) (4) . The efficacy of GRP94/gp96 in animal model studies of tumor rejection has spurred investigation into tumor-derived chaperones, principally GRP94/gp96, as immunotherapeutics for human cancers (5-7). The tumor-rejection properties of these proteins have been proposed to reflect a peptide-binding function (8 -11) . In this view, GRP94/gp96-peptide complexes are escorted to the MHC class I antigen presentation pathways of antigenpresenting cells (APC) to yield re-presentation of the GRP94/ gp96-bound peptides on APC MHC class I molecules and activation of tumor directed CD8(ϩ) T lymphocytes (8 -11) .
However, recent data demonstrate that chaperone-elicited tumor rejection stems, at least in part, from the direct interactions of these proteins with antigen-presenting cells, to yield dendritic cell (DC) maturation (12) (13) (14) (15) (16) and migration (17) , and the release of cytokines known to exert anti-tumor effects, including TNF-␣, IL-12, IL-1␤, and GM-CSF (10, 12, 13, 18, 19) . Additionally, several chaperones, including GRP94/gp96, have been implicated in stimulating nitric oxide (NO) production by macrophages and DC (18, 20) . Importantly, these peptide-independent activities are, under some circumstances, apparently sufficient to account for GRP94/gp96-elicited tumor rejection. For example, prophylactic vaccination of mice with irradiated fibroblasts, engineered to secrete GRP94/gp96 or the GRP94/gp96 N-terminal domain, yielded a marked suppression of 4T1 mammary carcinoma growth and metastasis following tumor cell challenge (15) . It thus appears that GRP94/gp96-elicited, peptide-independent APC stimulation can play a prominent, if not primary, role in the phenomenon of chaperone-elicited tumor rejection.
Several recent studies have investigated the peptide-independent mechanism(s) by which chaperones stimulate APC, implicating Toll-like receptors (TLR) and CD14 as well as a variety of downstream signaling cascades. TLR generally recognize pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS), CpG oligonucleotides, and bacterial surface proteins such as flagellin (21) . Hsp60, for example, elicits TNF-␣ and NO release from murine macrophages in a TLR4-dependent manner, suggesting that TLR4 serves as a signaling receptor for Hsp60 (22) . TLR2 and 4 have also been identified as Hsp70 signaling receptors, as determined through ectopic receptor expression studies (23, 24) , and as GRP94/gp96 signaling receptors, based on similar experiments, as well as studies performed on cells derived from TLR4 Ϫ/Ϫ mice (25) . CD14 is a GPI-anchored co-receptor for LPS that may interact with signaling receptors (26) ; work with Hsp70 indicates a CD14 requirement for cytokine release (19) . Evidence thus suggests that chaperone proteins are recognized by receptors of the innate immune system, principally those involved in the recognition of LPS and other PAMPs, to yield peptide-independent activation of APC function.
At least four signaling pathways have been described in the literature for GRP94/gp96-elicited APC activation. First, GRP94/gp96 signaling by activation of NF-B has been identified by electrophoretic mobility shift assay (12) and by the loss of IB␣ by immunoblot (25) . Additionally, MAP kinase phosphorylation has also been observed in response to GRP94/gp96; immunoblotting for phospho-p38, JNK, and ERK demonstrated increases in the phosphorylated (active) form of each, in response to GRP94/gp96 addition (25) .
It has been observed that the patterns of APC stimulation by GRP94, Hsp70, and Hsp60 bears many similarities to stimulation by LPS, in their kinetics, signaling pathways, and resulting cellular changes (12, 22, 24) , though significant differences between LPS and GPR94/gp96, with respect to specific cellular effects and kinetics of activation, have been reported (12) . LPS, which is found on the surface of Gram-negative bacteria, is a problematic contaminant: it is very chemically stable and a potent activator of APC activation (26) , and is generally present in protein preparations unless specifically excluded. In fact, LPS levels as low as 15 pg/ml can stimulate some markers of activation in APC, including p38 phosphorylation and IL-6 release (27) .
Several recent reports have revived longstanding concerns about LPS contamination in purified chaperone preparations. The ability of recombinant human Hsp70 to induce TNF-␣ release from macrophages has recently been attributed to LPS contamination (28) . Similarly, Bausinger et al. (27) report that recombinant human Hsp70 does not cause DC maturation or cytokine release when endotoxin levels are extremely low (less than 10 EU/mg protein). On a related note, an established GRP94/gp96 purification protocol was recently found to result in substoichiometric contamination of GRP94 by concanavalin A (29) , raising the possibility that other, heretofore undetected, contaminants may be present in biochemically enriched chaperone preparations.
Peptide-independent stimulation of APC appears to be a central event in chaperone-mediated immune tumor rejection. Moreover, despite reports that LPS contamination accounts for some of the APC stimulation attributed to chaperones, it is evident that GRP94/gp96, at least, elicits tumor suppression in the absence of LPS. In systems in which GPR94 is secreted from cultured cells in vivo, suppression of tumor growth and metastasis is significant, peptide independent, and characterized by activation of innate immune mechanisms including DC maturation and NK cell activation (15, 30) . It becomes paramount, then, to understand the mechanism whereby GRP94/ gp96 elicits APC activation. For these reasons, we investigated whether LPS was responsible for any of the immunostimulatory activities reported for GRP94/gp96. We also tested CRT, a luminal chaperone with tumor-rejection activity similar to that of GRP94/gp96 (3, 4) , whose ability to stimulate an innate immune response has not been characterized. Here, we report that GRP94/gp96 specifically binds LPS, and that low endotoxin preparations of GRP94/gp96 and CRT do not stimulate NF-B activation or NO release in macrophages; both responses are, however, robustly stimulated by LPS. Low endotoxin GRP94/gp96 and CRT do induce ERK phosphorylation in macrophages, implicating the MAP kinase cascade in the phenomenon of peptide-independent GRP94/gp96-and CRTelicted APC activation.
EXPERIMENTAL PROCEDURES
Materials-LPS levels were determined using the QCL-1000 Limulus amoebocyte lysate kit (Cambrex, Walkersville, MD). Escherichia coli LCD25-09 LPS was labeled and purified by the method of Munford et al. (32) is a rabbit polyclonal antibody directed against a domain in the GRP94 N terminus and was prepared by contract service with Cocalico Biologicals (Reamstown, PA). A rabbit antiserum against BiP was prepared by contract service with Cocalico Biologicals, using a synthetic peptide representing the 15 N-terminal amino acids of the human protein. All other reagents were purchased from Sigma.
Purification of GRP94/gp96 and Calreticulin-Low endotoxin GRP94/gp96 was purified from porcine pancreas rough microsomes by a modification of the method of Wearsch and Nicchitta (33) . In this modification, chromatography buffers were supplemented with detergents, as described below, to yield the efficient removal of LPS. All materials were decontaminated prior to use, either by soaking in 70% EtOH, 0.5 M acetic acid (34) , or by baking for 4 h at 200°C. All buffers were made in pyrogen-free water. Following microsome permeabilization, luminal proteins were loaded on a Mono Q column (Amersham Biosciences) equilibrated in TTTE buffer (25 mM Tris-Cl, pH 7.8, 150 mM NaCl, 0.2% (v/v) Tween 20, 0.2% (v/v) Triton X-100, and 10 mM EDTA). The column was washed sequentially with 400 ml of TTTE, 400 ml of 25 mM Tris-Cl, pH 7.8, 150 mM NaCl, and 1% (v/v) Triton X-114, and 250 ml of 25 mM Tris-Cl, pH 7.8, 50 mM NaCl. A 50 -750 mM NaCl gradient was run to elute the column, and gel filtration was performed as usual, except that the column was equilibrated and run in sterile PBS. CRT was purified from porcine pancreas rough microsomes by the method of Wearsch and Nicchitta (33) , and subsequently decontaminated of LPS using polymyxin B-agarose beads, by the method of Wright et al. (35) . Briefly, purified CRT was incubated overnight with polymyxin B-agarose beads in a buffer containing 25 mM K-HEPES (pH 7.4), 20 mM NaCl, 110 mM KOAc, 2 mM Mg(OAc) 2 (36) .
GRP94/gp96 Fluorescent Labeling and Cell Binding-Low endotoxin GRP94/gp96 was labeled with fluorescein isothiocyanate (FITC) (Molecular Probes, Eugene, OR) to a ratio of ϳ1 mol of FITC:mol GRP94/gp96 dimer. Labeling was performed according to the manufacturer's instructions. FITC-GRP94 binding to cells was performed as described in Wassenberg et al. (37) and evaluated by flow cytometry.
Citrate Synthase Aggregation Assay-The effects of low endotoxin GRP94/gp96 on the thermal aggregation of citrate synthase were assayed essentially as described in Buchner et al. (38) . Binding buffer (40 mM HEPES, pH 7.5) was preheated to 43°C. Samples containing no protein, or GRP94 (0.6 M final), were then added to 400 l of preheated binding buffer in a quartz microcuvette. The cuvette was placed in a spectrofluorometer (Spex Industries, Inc., Edison, NJ) thermostatted at 43°C. Citrate synthase was then added to 0.15 M final concentration, with stirring. Thermal aggregation of citrate synthase was recorded as light scattering, with excitation and emission wavelengths of 500 nm and a 1-nm slit width. The time course of citrate synthase aggregation was followed for 1200 s. Readings were taken every 15 s with a 5-s integration.
NF-B Activation Assay-Activation of the NF-B signaling pathway was determined using the PathDetect NF-B cis-reporting system (Stratagene, La Jolla, CA). RAW264.7 cells were plated to 80% confluence in 24-well plates and transfected with 0.5 g each of pLuc-NFB and pCMV-␤Gal (as a transfection efficiency control) for 5 h in the presence of LipofectAMINE (Invitrogen Life Technologies, Carlsbad, CA), as per manufacturer's protocols, then cultured in DMEM with 10% fetal bovine serum for an additional 21 h. Transfected cells were stimulated with GRP94/gp96, CRT, ConA and/or LPS for 4 h and lysed in Reporter Lysis Buffer (Promega, Madison, WI) with a freeze-thaw cycle. Luciferase levels were measured using the Promega luciferase assay system. ␤-Galactosidase levels were determined by CPRG assay, as in Reed et al. (39) . Luciferase levels were normalized to ␤-galactosidase levels for analysis. All reactions were performed in triplicate and corrected by subtraction of the luciferase level of transfected, untreated cells.
Nitrite Release Assay-Production of nitrite, a measure of nitric oxide release, was determined with the method of Misko et al. (40) , using 2,3-diaminonaphthalene (Molecular Probes). Fluorometer (Spex Industries, Inc.) slit widths were set to 1 nm for both excitation and emission. Samples were excited at a wavelength of 365 nm and the emission at 450 nm was recorded. All reactions were performed in duplicate and corrected by subtraction of background fluorescence.
Determination of MAP Kinase Activation-Peritoneal mouse macrophages were isolated from BALB/c mice by peritoneal lavage with DMEM, 10% FCS, 5-7 days after intraperitoneal injection of 1 ml 4.2% (w/v) brewer's thioglycollate broth. Macrophages were plated in 24-well plates (Corning Glass Works, Corning, NY) and selected by adherence for 1 h at 37°C. The cells were then incubated for 7 h at 37°C in serum-free DMEM. Cells were supplemented with the indicated concentrations of low endotoxin GRP94/gp96, low endotoxin calreticulin or CpG oligonucleotide in serum-free DMEM for the times indicated. At the end of the incubation, cells were washed in PBS, and lysed on ice in phosphoprotein lysis buffer (150 mM NaCl, 50 mM sodium phosphate (pH 7.4), 0.05% (w/v) SDS, 1% (w/v) Nonidet P-40, 2 mM EDTA, 50 mM NaF, 100 M NaVO 4 , 1 mM phenylmethylsulfonyl fluoride, and 0.1 mg/ml soybean trypsin inhibitor). Cells were removed from the wells with a cell scraper, centrifuged at 15,000 rpm at 4°C for 10 min, and the supernatants trichloroacetic acid-precipitated. After washing in acetone, protein pellets were resuspended in sample buffer, resolved by SDS-PAGE on a 10% acrylamide gels, transferred to nitrocellulose membranes and probed with anti-phosphoprotein antibodies according to the manufacturer's instructions. As an internal loading control, endogenous GRP94/gp96 levels were determined by Western blot using DU120. Quantification was performed with NIH Image 1.63 (National Institutes of Health, Bethesda, MD).
RESULTS

GRP94/gp96 Is an LPS-binding Protein-Current evidence
indicates that peptide-independent activation of APC by chaperone proteins plays a fundamental role in the phenomenon of chaperone-elicited antitumor immunity. However, LPS is a common contaminant in purified chaperone preparations, and in the case of Hsp70, recent studies have indicated that contaminating LPS is responsible for all aspects of APC activation tested (27, 28) . We therefore sought to determine, in the case of GRP94/gp96 and CRT, which aspects of APC activation were chaperone versus LPS-mediated.
To distinguish the effects of LPS from those of GRP94/gp96 and CRT on macrophage stimulation, we set out to purify very low endotoxin GRP94/gp96 and CRT. CRT can be decontaminated by incubation with polymyxin B-agarose beads (41) . However, we observed that GRP94/gp96 binds polymyxin B beads, making this purification method unsuitable (Fig. 1A) . Interestingly, during the gel filtration step of our GRP94 purification (33) , LPS present in the Mono Q pool eluted in the same fractions as GRP94/gp96 (Fig. 1B) . Subsequent attempts to separate GRP94/gp96 from LPS by repeating this gel filtration step demonstrated that LPS continued to coelute with purified GRP94/gp96 (data not shown).
These findings, which suggested a GRP94/gp96-LPS association, raised the question of whether GRP94/gp96 specifically binds LPS. LPS-GRP94/gp96 interactions were examined in a radioligand binding assay. (Fig. 1C) . The binding was competed by an 50-fold excess of cold LPS, but was unaffected by heat treatment of GRP94/gp96, which is known to elicit a tertiary conformational change associated with peptide binding (42) ; radicicol, which binds to the Nterminal regulatory domain of GRP94 and Hsp90 and serves as a pan-Hsp90 inhibitor; or a 50-fold molar excess of SIINFEKL peptide, which was previously demonstrated to bind to GRP94/ gp96 (43) (Fig. 1C) . In addition, LPS binding was saturable (Fig. 1D) Chromatographic Purification of Functional, Low Endotoxin GRP94/gp96 -Because LPS could not be removed from GRP94/gp96 by conventional techniques such as polymyxin B incubation, low endotoxin GRP94/gp96 was purified by a detergent extraction protocol, as described under "Experimental Procedures." Elution from the Mono Q and gel filtration chromatography were performed as described previously (33) . In conjunction with chemical decontamination of all reagents and chromatography equipment, this method yielded GRP94/gp96 with a very low LPS content: by LAL assay, endotoxin levels were Ͻ0.27 EU/mg protein, or Ͻ0.027 pg/g GRP94/gp96. Calreticulin, which was decontaminated by 1-2 rounds of polymyxin B treatment, contained Ͻ0.01 EU/g protein. Low endotoxin GRP94/gp96 retained its native properties following purification; specifically, the protein ran as a single, 96-kDa band on SDS-PAGE ( Fig. 2A) and bound N-
, an adenosine-bearing nucleoside that functions as a high affinity ligand for the GRP94/gp96 N-terminal regulatory domain. NECA binding by GRP94/gp96 is a functional assay highly sensitive to conformational change (36) (Fig. 2B) . In addition, FITC-conjugated low endotoxin GRP94/gp96 was recognized by cell surface receptors of elicited murine peritoneal macrophages, but not HepG2 or CHO cells (44) (Fig. 2C) . Finally, the ability of low endotoxin GRP94/gp96 to chaperone other proteins was examined in a thermal aggregation assay (45) . As with GRP94/gp96 purified by conventional means, low endotoxin GRP94/gp96 efficiently prevented the thermal aggregation of citrate synthase, demonstrating that it retains its chaperone activity (Fig. 2D) .
Low Endotoxin GRP94/gp96 and CRT Do Not Activate NF-B Signaling-The high affinity of GRP94/gp96 for LPS suggested that endotoxin contamination of this protein might occur frequently during purification, and that otherwise highly purified GRP94/gp96 may contain biologically significant levels of LPS. This is of concern because the reported effects of GRP94/gp96 on antigen-presenting cells are similar to those of LPS on these cells. GRP94/gp96 has been reported to activate NF-B (12) via the TLR 2/4 signaling pathway (25) and iNOS induction and nitric oxide release (20) , a cascade also typical of LPS signaling (46) . Although its cell signaling properties have not been examined, calreticulin possesses immunostimulatory properties similar to GRP94/gp96 (4). We therefore examined the ability of low endotoxin GRP94/gp96 and low endotoxin CRT to activate NF-B in RAW264.7 macrophages, using a luciferase reporter assay. The reporter construct contains tandem repeats of NF-B binding elements upstream of the luciferase coding region. When NF-B is released from IB-mediated inhibition, it binds these elements, yielding transcription of luciferase, which can then be detected by luciferin assay. GRP94/gp96 and CRT did not activate NF-B above baseline levels at concentrations of 30 and 20 g/ml, respectively (Fig.  3A) . By contrast, LPS induced a robust luciferase signal, detectable at concentrations as low as 100 pg/ml (Fig. 3, A-C) . 25 g/ml GRP94/gp96 and 40 g/ml CRT did not potentiate the ability of LPS to elicit NF-B activation (Fig. 3, B and C) .
A recent report states that GRP94/gp96 purified by methods involving ConA affinity chromatography contains substoichiometric quantities of ConA (29) . To investigate whether ConA, alone or in conjunction with GRP94/gp96, activates NF-B
FIG. 1. GRP94/gp96 is an LPS-binding protein.
A, 2 g of purified CRT or GRP94/gp96 were incubated with polymyxin B beads for 6 h at 4°C. The beads were removed by centrifugation, washed, and any bound protein eluted in sample buffer. For each chaperone, the starting protein, supernatant, and polymyxin B-bound fractions were analyzed by SDS-PAGE and Coomassie Blue staining. B, rough microsomes were permeabilized and the luminal extract fractionated over Mono Q anion exchange by the method of Wearsch and Nicchitta (33) . Fractions containing GRP94/gp96 and CRT were pooled and fractionated over a Superdex 26/60 200 gel filtration column, and the fractions tested for LPS by the LAL assay (dashed line). GRP94 and CRT peaks (solid line) were identified by SDS-PAGE analysis. C, in triplicate, 2 g of low endotoxin GRP94/gp96 was incubated with 10 nM [ 3 H]LPS for 1 h on ice, and the bound [ 3 H]LPS separated from free ligand by vacuum filtration. The average counts per minute minus background (no protein added) are depicted; error bars represent S.D. ϩHS, GRP94/gp96 was first heat-shocked at 50°C for 15 min; ϩpep, 500 nM SIINFEKL was added to the incubation; ϩRD, 1 M radicicol was added; ϩcold LPS, 2 g/ml LPS was added; ova, 2 g of ovalbumin was used in place of GRP94/ gp96. D, in triplicate, 2 g of low endotoxin GRP94/gp96 was incubated with the indicated amounts of 
FIG. 2. Low endotoxin GRP94/gp96 is in its native conformation.
A, low endotoxin GRP94/gp96 was purified as described under "Experimental Procedures"; 2 g of purified GRP94/gp96 was analyzed by SDS-PAGE and Coomassie Blue staining. B, in triplicate, 6 g of low endotoxin GRP94/gp96 or ovalbumin was incubated with 20 nM [ 3 H]N-ECA for 1 h on ice, and the bound [ 3 H]NECA separated from free ligand by vacuum filtration. The average counts per minute minus background (no protein added) are depicted; error bars represent S.D. C, low endotoxin GRP94/gp96 was labeled with fluorescein and incubated with the cell types indicated at 50 g/ml for 1 h on ice. The cells were washed six times in cold PBS, fixed in 4% paraformaldehyde, and analyzed by flow cytometry. D, citrate synthase was diluted to 0.15 M in buffer containing no GRP94/gp96 or 0.6 M low endotoxin GRP94/gp96, and citrate synthase aggregation at 43°C was monitored by light scattering at 500 nm in a thermostatted spectrofluorometer. The figure depicts an average of three independent experiments. Bovine serum albumin did not affect aggregation (data not shown).
signaling, the effect of tissue culture-grade ConA on NF-B signaling in RAW-264.7 cells was assayed using the luciferase reporter method. We found that ConA did not activate NF-B signaling, nor did it potentiate the ability of GRP94/gp96 to activate NF-B (Fig. 3D) .
Low Endotoxin GRP94/gp96 and CRT Do Not Activate Nitric Oxide Production-Another activity attributed both to LPS (46) and to GRP94/gp96 (20) is the ability to induce the release of nitric oxide by macrophages, by upregulating synthesis of the inducible nitric-oxide synthase, iNOS. We therefore examined whether low endotoxin GRP94/gp96 and CRT induce nitric oxide in macrophages. RAW-264.7 cells were incubated for 17 h with stimulating compounds, and subsequently assayed for production of nitrates and nitrites. In the presence of GRP94/ gp96 concentrations as high as 100 g/ml, and CRT concentrations as high as 30 g/ml, RAW264.7 macrophages did not produce NO at levels above baseline. By contrast, LPS at 100 ng/ml increased nitrate and nitrite production by 8 -11-fold (Fig. 4A) . ConA, at concentrations up to 10 g/ml, did not elicit NO production (data not shown).
To further examine the effects of low endotoxin GRP94/gp96 and CRT on the nitric oxide signaling cascade, we examined whether iNOS is synthesized in the presence of these proteins. RAW-264.7 cells were incubated overnight with 100 g/ml GRP94/gp96 or 30 g/ml CRT and their lysates probed with anti-iNOS antibody. We observed that low endotoxin GRP94/ gp96 and CRT-treated cells did not produce iNOS; however, FIG. 3 . Low endotoxin GRP94/gp96 and CRT do not activate NF-B signaling. A, in triplicate, RAW264.7 cells were cotransfected with pLuc-NFB and pCMV-␤Gal for 24 h, then stimulated with LPS, GRP94/gp96 or CRT, as indicated, for 4 h. Luciferase and ␤-galactosidase activities were assayed and the ␤-galactosidase-corrected luciferase level calculated. The average luciferase activity is depicted; error bars represent S.D. B, transfected RAW264.7 cells were stimulated with LPS alone or LPS with 25 g/ml low endotoxin GRP94/gp96 and assayed as above. C, transfected RAW 264.7 cells were stimulated with LPS alone or LPS with 40 g/ml low endotoxin CRT and assayed as above. D, transfected RAW264.7 cells were stimulated with 100 ng/ml LPS, ConA, or ConA with 25 g/ml low endotoxin GRP94/gp96 and assayed as above.
FIG. 4. Low endotoxin GRP94/gp96 and CRT do not activate NO signaling.
A, in duplicate, RAW-264.7 cells were incubated with no added material, 100 ng/ml LPS, 100 g/ml low endotoxin GPR94, or 30 g/ml low endotoxin CRT for 17 h. NO production was assayed using the fluorometric assay of Misko et al. (1993) . Average fold induction of NO release is depicted; error bars represent S.D. B, RAW-264.7 cells were incubated with no added material, 100 ng/ml LPS, 100 g/ml low endotoxin GPR94, or 30 g/ml low endotoxin CRT for 17 h. Cells were washed in PBS and lysed, and the lysates were separated by SDS-PAGE, transferred to nitrocellulose and probed with an anti-iNOS antibody. GRP94/gp96 and BiP immunoblots are depicted as lane loading controls.
overnight incubation with 100 ng/ml LPS yielded robust iNOS production (Fig. 4B) . From these data we conclude that low endotoxin GRP94/gp96 and CRT are not inducers of nitric oxide signaling in a murine macrophage cell line.
Low Endotoxin GRP94/gp96 and CRT Activate ERK Phosphorylation in Macrophages-A recent report demonstrates that GRP94/gp96 stimulates p38, JNK, and ERK phosphorylation (25) . Because, in the case of Hsp70, p38 phosphorylation occurs only in preparations containing moderate or greater levels of LPS (27), we investigated whether our low endotoxin GRP94/gp96 or CRT-stimulated phosphorylation of these MAP kinases. Thioglycollate-elicited mouse peritoneal macrophages were selected by adherence, starved of serum for 7 h and treated with low endotoxin GRP94/gp96 or CRT; we used 1 M sorbitol as a positive control for p38 stimulation (47) , and CpG oligonucleotide as a positive control for ERK stimulation (25) . By immunoblotting with anti-phosphoprotein antibodies, we determined that GRP94/gp96 and CRT do not cause p38 phosphorylation at concentrations up to 25 g/ml, over a time course of 5-60 min. The level of p38 phosphorylation in GRP94/ gp96 and CRT-stimulated cells was unaffected by the addition of 20 M SB203580 (a p38 MAP kinase inhibitor), but phosphop38 did increase in response to osmotic shock with sorbitol, indicating that the macrophages were capable of upregulating this pathway (data not shown). We also observed no change in the level of JNK phosphorylation in response to 25 g/ml low endotoxin GRP94/gp96 or CRT at any time from 5-60 min (data not shown).
Immunoblotting with anti-phospho-ERK antibody showed a GRP94/gp96-dependent increase in ERK phosphorylation, peaking at 1.7-fold above background (Fig. 5, A and B) . The kinetics of ERK stimulation varied reproducibly by which chaperone was used to stimulate: GRP94/gp96-mediated ERK phosphorylation peaked at 30 min, while CRT-mediated ERK phosphorylation peaked at 10 min and subsequently declined (Fig.  5B) . ERK stimulation occurred at low concentrations of GRP94/ gp96 and CRT; 2 g/ml of each was sufficient to stimulate maximal phosphorylation. Both CpG oligonucleotide-and GRP94/gp96-mediated ERK phosphorylation were abrogated by 20 M PD98059, an inhibitor of MEK, the ERK kinase (Fig.  5C ). DISCUSSION Chaperone proteins have been reported to act upon a number of pathways of innate immune recognition and stimulation, including DC maturation, cytokine release by DC and macrophages, and NO production by macrophages (12) (13) (14) 20) . However, the pattern of activation attributed to these proteins bears a strong resemblance to that caused by LPS, a common contaminant in both recombinant and native protein preparations. Validating this concern, we show here that GRP94/gp96 binds with high affinity to LPS, although very low endotoxin preparations of both GRP94/gp96 and CRT can be prepared using either a series of detergent washes or incubation with polymyxin B beads, respectively. Low endotoxin GRP94/gp96 and calreticulin fail to activate NF-B signaling in macrophages by luciferase reporter assay; by contrast, LPS at concentrations as low as 100 pg/ml yields activation above background. Similarly, we observe no NO production or iNOS synthesis in the presence of low endotoxin GRP94/gp96 and calreticulin, even at high protein concentrations. Here again, LPS yields robust iNOS induction and NO release. Both GRP94/gp96 and CRT do induce rapid phosphorylation of ERK, at concentrations as low as 2 g/ml, indicating that this signaling pathway, but not NF-B activation, is mediated by the chaperones and not by contaminating endotoxin.
We found that GRP94/gp96 specifically binds LPS with high affinity. There is evidence that Hsp90, a close relative of GRP94, binds LPS: incubation of purified Hsp90 with [ 3 H]LPS yields radioactive complexes following native gel electrophoresis, and the association can be competed with cold LPS (48) . Furthermore, Hsp70 and Hsp90 were isolated by affinity chromatography of cellular lysates on an immobilized LPS column, and these associations were confirmed by FRET (49) . In the studies reported herein, we demonstrate that GRP94/gp96 displays saturable, specific, and competable binding of LPS. It is interesting to note that binding is not affected by the Hsp90 family-specific drug radicicol, by synthetic peptides, or by heat shock.
Our findings concerning signaling pathways of GRP94/gp96 and CRT versus LPS contrast, in part, with those of several previous investigations into GRP94/gp96-mediated APC activation, which found that GRP94/gp96 activates NF-B, NO FIG. 5 . Low endotoxin GRP94/gp96 and CRT activate ERK phosphorylation. A, serum-starved thioglycollate-induced mouse peritoneal macrophages were supplemented with 2 g/ml CpG oligonucleotide or 25 g/ml low endotoxin GRP94/gp96 or CRT for the indicated times. Cells were washed in PBS and lysed, and the lysates were separated by SDS-PAGE, transferred to nitrocellulose and probed with an anti-phospho-ERK antibody. B, band density was quantified using NIH Image 1.63 and normalized to GRP94/gp96 density, as determined by immunoblotting with anti-GRP94/gp96 antibody. Open rectangles represent GRP94/gp96 responses; closed circles represent CRT responses. C, serum-starved thioglycollate-induced mouse peritoneal macrophages were preincubated with Me 2 SO 0.1% or 20 M PD98057, where indicated, for 30 min, then supplemented with 5 g/ml CpG oligonucleotide or the indicated quantity of low endotoxin GRP94/gp96 or CRT. CpG oligonucleotide and GRP94/gp96 incubations were carried out for 30 min; CRT incubations for 10 min. Cells were washed in PBS and lysed, and the lysates were separated by SDS-PAGE, transferred to nitrocellulose and probed with an anti-phospho-ERK antibody. As a lane loading control, the blot was probed with anti-GRP94/gp96 antibody.
release and p38 and JNK phosphorylation (12, 25) . A possible source of difference is the degree of endotoxin contamination present in our protein preparations and those used by other investigators. The GRP94 used in the experiments described in the current paper contained Ͻ 0.27 EU/mg endotoxin; other studies of GRP94/gp96 signaling have used GRP94/gp96 containing Ͻ50 EU/mg (25) or "Ͻ0.02 EU in absolute quantity" (12) . In the latter citation, EU levels per weight of protein were not provided.
Two recent studies, using Hsp70, have investigated the role of LPS contamination in APC activation. In a comparison of Hsp70 purified by standard methods, and containing 577 EU/mg endotoxin, versus that purified to reduce endotoxin levels (low endotoxin Hsp70, 4.1 EU/mg), the low endotoxin protein did not elicit TNF-␣ from macrophages at 5 g/ml; however, Hsp70 at 577 EU/mg and 100 pg/ml LPS were both sufficient to do so (28) . Another group distinguished between "endotoxin-contaminated" (400 -4500 EU/mg), "low endotoxin" (56 EU/mg) and "very low endotoxin" (Ͻ10 EU/mg) Hsp70, and observed that different events appear to require different levels of endotoxin contamination. DC maturation took place only in the presence of endotoxin-contaminated Hsp70 at 3 g/ml, while both endotoxin-contaminated and low endotoxin Hsp70 at 3 g/ml induced cytokine release and rapid p38 phosphorylation in DC. However, although it remained functional by several criteria, very low endotoxin Hsp70 did not induce cytokine release or p38 phosphorylation in DC, events stimulated by LPS at concentrations as low as 15 pg/ml (27) . In a commercially available "low endotoxin" GRP94/gp96 preparation containing Ͻ50 EU/mg of endotoxin (Immatics Biotechnologies, Tubigen, Germany), a GRP94/gp96 concentration of 3 g/ml, assuming 50 EU LPS/mg, provides this level of LPS. These reports reveal an exquisite sensitivity to LPS by APC, as well as differing thresholds of activation, depending on the cell type (macrophage or DC) and the phenomenon being measured (DC activation, cytokine release, p38 phosphorylation).
Moreover, several lines of evidence argue that controls routinely performed to ensure that LPS is not the agent causing stimulation (polymyxin B treatment, heat inactivation) cannot reliably be interpreted as ruling out a role for LPS. Polymyxin B, which binds LPS, is often added to assays to sequester the LPS (12, 18, 23) . However, one recent study reports that polymyxin B does not fully abrogate LPS-mediated cytokine secretion (27) , while another group has observed no effect by polymyxin on the ability of an LPS-contaminated Hsp70 fraction to stimulate DC (50) . Additionally, we report here that polymyxin B binds GRP94/gp96 with a high affinity, making it unsuitable for inclusion as a control in experiments using GRP94/gp96. Similarly, chaperone proteins are frequently treated by heat inactivation, in theory inactivating the protein while leaving the LPS active (24) . A recent report that LPS is itself heat sensitive, especially at low concentrations (20 ng/ml), but also at higher ones (20 g/ml), challenges the validity of this assumption (28) . These findings indicate that such controls may not be valid under all circumstances and make clear the need for conservative interpretations of such experiments.
Experimental systems using cell-secreted GRP94/gp96 or GRP94/gp96 domains circumvent the problem of trace LPS contamination by avoiding purification altogether. A secreted GRP94-IgG fusion, when expressed by tumor cells, elicits a vigorous CD8ϩ T cell response and subsequent tumor rejection (51) . There is evidence the fusion protein affects the innate immune system as well as the acquired; when expressed in vivo, the secreted protein causes NK cell activation (30) . In a second system, two truncated forms of GRP94/gp96, one lacking the KDEL ER retrieval sequence and the other consisting only of the geldanamycin-binding N-terminal domain, were secreted from irradiated, transfected cells. In addition to mediating tumor rejection in mice, regardless of the source of the GRP94/gp96, media conditioned by GRP94/gp96-secreting cells also elicited DC maturation, as measured by MHC class II and CD86 up-regulation (15) . Because these studies were performed in tissue culture systems and thus the potential for LPS contamination was greatly reduced, they demonstrate that chaperones (at least, chaperones secreted from transfected cells) can indeed elicit innate immune responses in vitro and in vivo.
Using GRP94/gp96 and CRT containing very low endotoxin levels, we demonstrate that low concentrations (2 g/ml) of both proteins elicit rapid ERK phosphorylation, indicating activation of the MAP kinase cascade. It is possible that p38 and JNK are also activated by GRP94/gp96 and CRT, since small changes in the phosphorylation state of kinases may be amplified downstream; however, we could not detect such activity. In this regard, it is noteworthy that LPS elicits activation of the combined ERK, JNK, and p38 pathways. We calculate that the effective LPS concentration in a 2 g/ml solution of our GRP94 is 0.0524 pg/ml, nearly 300-fold below the lowest reported threshold for any known LPS elicited, APC stimulatory process. On the basis of these data, we conclude that GRP94/gp96 and CRT can indeed serve as an activation signal for APC.
ERK phosphorylation, an event downstream of Ras, Raf proteins, and MAP kinase kinase, is commonly observed in response to growth factors, cytokines, and viral infection, among other stimuli (52) . That ERK activation occurs in response to chaperone binding is therefore plausible: even in the chaperone-secreting systems described above, chaperones possess activity reminiscent of some inflammatory cytokines and growth factors. Moreover, ERK activation appears to be sufficient to cause elaboration of cytokines, a probable downstream effect of macrophage stimulation, under at least some circumstances. For example, nerve growth factor, for which macrophages posses a receptor, induces TNF-␣ production in macrophages by signaling through ERK and JNK, but not p38, cascades; pharmacological ERK inhibition abrogates TNF-␣ production (53) . Studies in human and murine DC suggest that ERK activation plays a different role in DC, that of a maturation inhibitor (54, 55) . The DC maturation observed in experimental systems of secreted GRP94/gp96 (15, 30) may therefore require additional signaling mechanism(s) which, as yet, remain to be identified. We conclude that macrophage NF-B activation and NO production are mediated by LPS signaling whereas ERK activation is mediated by GRP94/gp96 and CRT, independent of contaminating endotoxin.
